Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy.

Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM.

Support Care Cancer. 2019 Jan;27(1):7-8. doi: 10.1007/s00520-018-4528-z. Epub 2018 Oct 29. No abstract available.

PMID:
30374766
2.

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Gewandter JS, Chaudari J, Ibegbu C, Kitt R, Serventi J, Burke J, Culakova E, Kolb N, Sluka KA, Tejani MA, Mohile NA.

Support Care Cancer. 2019 May;27(5):1765-1774. doi: 10.1007/s00520-018-4424-6. Epub 2018 Aug 27.

PMID:
30151681
3.

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM.

Support Care Cancer. 2018 Apr;26(4):1019-1028. doi: 10.1007/s00520-017-4013-0. Epub 2017 Dec 14.

4.

Medical Complications of Brain Tumors.

Mohile NA.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1635-1652. doi: 10.1212/CON.0000000000000540. Review.

PMID:
29200115
5.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.

Chinnaiyan P, Won M, Wen PY, Rojiani AM, Werner-Wasik M, Shih HA, Ashby LS, Michael Yu HH, Stieber VW, Malone SC, Fiveash JB, Mohile NA, Ahluwalia MS, Wendland MM, Stella PJ, Kee AY, Mehta MP.

Neuro Oncol. 2018 Apr 9;20(5):666-673. doi: 10.1093/neuonc/nox209.

6.

Palliative and end-of-life care in glioblastoma: defining and measuring opportunities to improve care.

Hemminger LE, Pittman CA, Korones DN, Serventi JN, Ladwig S, Holloway RG, Mohile NA.

Neurooncol Pract. 2017 Sep;4(3):182-188. doi: 10.1093/nop/npw022. Epub 2016 Sep 27.

7.

Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations.

Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH.

Neurology. 2017 Aug 22;89(8):859-869. doi: 10.1212/WNL.0000000000004272. Epub 2017 Jul 26. Review.

PMID:
28747442
8.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro A.

Neuro Oncol. 2017 Oct 1;19(10):1380-1390. doi: 10.1093/neuonc/nox086.

9.

Reply.

Gewandter JS, Dworkin RH, Finnerup NB, Freeman R, Mohile NA.

Pain. 2017 Jan;158(1):182-183. No abstract available.

PMID:
27984531
10.

Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?

Gewandter JS, Dworkin RH, Finnerup NB, Mohile NA.

Pain. 2017 Jan;158(1):30-33. Review. No abstract available.

11.

Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era.

Herr MM, Mohile NA, Barr PM, van Wijngaarden E, Brown EB, Rich DQ.

Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):e123-e127. doi: 10.1016/j.clml.2016.06.009. Epub 2016 Jun 8. No abstract available.

PMID:
27375157
12.

Antidepressant use and risk of central nervous system metastasis.

Herr MM, Mohile NA, van Wijngaarden E, Brown EB, Rich DQ.

J Neurooncol. 2016 Aug;129(1):179-87. doi: 10.1007/s11060-016-2165-2. Epub 2016 Jun 11.

PMID:
27289477
13.

Solving the riddle of glioblastoma: The hope for immunotherapy.

Bashir R, Mohile NA.

Neurology. 2016 Jun 14;86(24):2220-1. doi: 10.1212/WNL.0000000000002779. Epub 2016 May 25. No abstract available.

PMID:
27225224
14.

Severe radiation-induced leukoencephalopathy: Case report and literature review.

Cummings M, Dougherty DW, Mohile NA, Walter KA, Usuki KY, Milano MT.

Adv Radiat Oncol. 2016 Feb 2;1(1):17-20. doi: 10.1016/j.adro.2016.01.002. eCollection 2016 Jan-Mar. No abstract available.

15.

How I treat glioblastoma in older patients.

Mohile NA.

J Geriatr Oncol. 2016 Jan;7(1):1-6. doi: 10.1016/j.jgo.2015.12.001. Epub 2015 Dec 22. Review.

PMID:
26725536
16.

Advances in Primary Central Nervous System Lymphoma.

Patrick LB, Mohile NA.

Curr Oncol Rep. 2015 Dec;17(12):60. doi: 10.1007/s11912-015-0483-8. Review.

PMID:
26475775
17.
18.

Diagnosis of primary CNS melanoma with neuroimaging.

Somers KE, Almast J, Biemiller RA, Silberstein HJ, Johnson MD, Mohile NA.

J Clin Oncol. 2013 Jan 1;31(1):e9-11. doi: 10.1200/JCO.2012.41.6115. Epub 2012 Nov 19. No abstract available.

PMID:
23169522
19.

Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis.

Mohile NA, Zoccoli CM, Glantz M.

Neurology. 2011 Mar 29;76(13):1118-20. doi: 10.1212/WNL.0b013e318212a928. Epub 2011 Feb 23. No abstract available.

PMID:
21346222
20.

Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.

Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1147-55. doi: 10.1016/j.ijrobp.2009.09.018. Epub 2010 Mar 6.

PMID:
20207495
21.

Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study.

Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA.

J Neurooncol. 2010 May;98(1):83-92. doi: 10.1007/s11060-009-0054-7. Epub 2009 Nov 7.

PMID:
19898743
22.

Utility of brain FDG-PET in primary CNS lymphoma.

Mohile NA, Deangelis LM, Abrey LE.

Clin Adv Hematol Oncol. 2008 Nov;6(11):818-20, 840.

PMID:
19194366
23.

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):156-63. doi: 10.1016/j.ijrobp.2008.10.043. Epub 2009 Jan 23.

24.

A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.

Mohile NA, Forsyth P, Stewart D, Raizer JJ, Paleologos N, Kewalramani T, Louis DN, Cairncross JG, Abrey LE.

J Neurooncol. 2008 Sep;89(2):187-93. doi: 10.1007/s11060-008-9603-8. Epub 2008 May 6.

PMID:
18458821
25.

The utility of body FDG PET in staging primary central nervous system lymphoma.

Mohile NA, Deangelis LM, Abrey LE.

Neuro Oncol. 2008 Apr;10(2):223-8. doi: 10.1215/15228517-2007-061. Epub 2008 Feb 20.

26.

Primary central nervous system lymphoma.

Mohile NA, Abrey LE.

Neurol Clin. 2007 Nov;25(4):1193-207, xi. Review.

PMID:
17964031
27.

Primary central nervous system lymphoma.

Mohile NA, Abrey LE.

Semin Radiat Oncol. 2007 Jul;17(3):223-9. Review.

PMID:
17591569
28.

T-cell lymphoma presenting with neurologic features in immunocompetent children.

Bassuk AG, Mohile NA, Stack C.

Pediatr Neurol. 2006 Nov;35(5):314-7.

PMID:
17074600
29.

Study of candida and Trichomonas vaginalis in Leucorrhoea.

Poria VC, Joshi BK, Agrawat HH, Mohile NA.

J Indian Med Assoc. 1989 Aug;87(8):184-5.

PMID:
2621360

Supplemental Content

Loading ...
Support Center